Regencell Bioscience HoldingsRGC 
$5.00-6.19%24h
-6.19%24h
Global rank4128
Market cap$65.06M
Change 7d-11.97%
YTD Performance-52.38%
SP500 benchmarkUnderperform
P/E-11.11
P/S0
Revenue$0
Earnings-$6.06M
Dividend yield-
Main Sector
Healthcare
Category
Regencell Bioscience Holdings (RGC) Cash on Hand
RGC Cash on Hand in 2022: $11.56M
According to Regencell Bioscience Holdings latest financial reports the cash on hand of RGC is $11.56M, an decrease of -29.56% to 2022. At the end of 2022 company had $16.42M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
RGC Cash on Hand History from 2019 to 2023
-
Value:-
RGC Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $11.56M | -29.56% |
| 2022 | $16.42M | 27532.00% |
| 2021 | $59.41K | -84.65% |
| 2020 | $386.98K | 59.05% |
| 2019 | $243.31K | - |
View the Top Cash on Hand Companies 
